# Impact of Intraoperative Deep Neuromuscular Blockade on NOL-guided Opioid Requirement in LSC Colorectal Surgeries

> **NCT03910998** · PHASE4 · UNKNOWN · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 100 (estimated)

## Conditions studied

- Laparoscopic Colorectal Surgeries

## Interventions

- **DRUG:** Rocuronium IV bolus 0.1 mg/kg guided by TOF that must remain between 1-3 during surgery
- **DRUG:** Rocuronium IV bolus 0.1 mg/kg guided by TOF 0/4 and PTC≤ 2

## Key facts

- **NCT ID:** NCT03910998
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-30
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03910998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03910998, "Impact of Intraoperative Deep Neuromuscular Blockade on NOL-guided Opioid Requirement in LSC Colorectal Surgeries". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03910998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*